Open AccessGiant cell arteritis. Part III. New trends in its treatment (role of genetically engineered drugs)
Author(s) -
А. М. Сатыбалдыев
Publication year - 2013
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2013-2364
Subject(s) - giant cell arteritis , tocilizumab , medicine , adalimumab , etanercept , vasculitis , infliximab , adverse effect , methylprednisolone , rituximab , randomized controlled trial , intensive care medicine , surgery , rheumatoid arthritis , lymphoma , disease